Cargando…
Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation
PURPOSE: We assessed the clinical outcomes and toxicities following hypofractionation with helical tomographic intensity-modulated radiotherapy technology (tomotherapy) in patients with stage III non-small cell lung cancer (NSCLC) who were not candidates for surgery or concurrent chemoradiation. MET...
Autores principales: | Li, Jing, Li, Hongqi, Wang, Yingjie, Liu, Junyang, Wang, Xuan, Pang, Haifeng, Chang, Dongshu, Di, Yupeng, Ren, Gang, Li, Ping, Wang, Yong, Liu, Chen, Chen, Xiao, Kang, Xiaoli, Xia, Tingyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345954/ https://www.ncbi.nlm.nih.gov/pubmed/32685544 http://dx.doi.org/10.1155/2020/9168424 |
Ejemplares similares
-
Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma
por: Liu, Xian, et al.
Publicado: (2016) -
Promising Clinical Outcome With Long Term Follow-Up After Body Gamma Knife Stereotactic Radiosurgery for Patients With Early Stage Non-small Cell Lung Cancer
por: Li, Hongqi, et al.
Publicado: (2018) -
Implementation of single-breath-hold cone beam CT guided hypofraction radiotherapy for lung cancer
por: Zhong, Renming, et al.
Publicado: (2014) -
First-Line Tyrosine Kinase Inhibitors Combined With Local Consolidative Radiation Therapy for Elderly Patients With Oligometastatic Non-Small Cell Lung Cancer Harboring EGFR Activating Mutations
por: Hu, Xiaolong, et al.
Publicado: (2022) -
Efficacy and Safety of Local Radiotherapy to All Oligometastatic Sites in Elderly Patients with Metachronous Oligometastatic Cancers After Initial Treatment for the Primary Tumor
por: Hu, Xiaolong, et al.
Publicado: (2021)